The global virus filtration market size was estimated at USD 4.26 billion in 2022 and is anticipated to grow at a compound annual growth rate (CAGR) of 10.1% from 2023 to 2030. The rising prevalence of chronic diseases such as cancer, diabetes, and autoimmune disorders is anticipated to propel the demand for biologics. According to the World Health Organization (WHO), around 422 million people globally are affected by diabetes. Rapid prevalence is observed in low- and middle-income nations compared to high-income nations. Amputation of the lower limbs is a common complication of diabetes, as are kidney disease, cardiac arrest, stroke, and blindness. According to the WHO, between 2000 and 2019, the mortality rates from diabetes rose by 3% for each age group and an estimated 2 million people died in 2019 from diabetes-related kidney disease.

Virus Filtration Market Report Highlights

• The consumables segment dominated the market with the largest revenue share in 2022 owing to the rising demand for these products for virus filtration.
• Chromatography technology segment is expected to grow at the fastest CAGR during the forecast period, owing to product advancements and increasing RD and production of biologics.
• Biologicals segment held the largest revenue share of 56.6% in 2022 and is expected to grow at the fastest CAGR of 10.9% over the forecast period due to rising prevalence of chronic diseases such as cancer, blood disorders, and diabetes
• The biotechnology and biopharmaceutical companies segment is projected to expand at the fastest CAGR over the forecast period owing to increasing investment in RD and production of biologics
• North America led the virus filtration market with the largest revenue share of 41.2% in 2022. Primarily due to the presence of several leading biotechnology companies and increased RD activities
• Asia Pacific is estimated to grow at the fastest CAGR of 12.0% over the forecast period from 2023 to 2030 due to the growing number of road accidents and trauma cases. 

Browse through Grand View Research's Biotechnology Industry Research Reports.

• The global whole genome sequencing market sizewas estimated at USD 2.12 billion in 2024 and is expected to grow at a CAGR of 22.17% from 2025 to 2030. 
• The global stem cells market sizewas estimated at USD 15.10 billion in 2024 and is expected to grow at a CAGR of 11.41% from 2025 to 2030.

Segments Covered in the Report

Grand View Research has segmented the global virus filtration market based on product, technology, application, end-use, and region:

Virus Filtration Product Outlook (Revenue, USD Million, 2018 - 2030)

• Consumables
  • Kits and Reagents
  • Others
• Instruments
  • Filtration Systems
  • Chromatography Systems
• Services

Virus Filtration Technology Outlook (Revenue, USD Million, 2018 - 2030)

• Filtration
  • Consumables
  • Instruments
  • Services
• Chromatography
  • Consumables
  • Instruments
  • Services

Virus Filtration Application Outlook (Revenue, USD Million, 2018 - 2030)

• Biologicals
  • Vaccines and Therapeutics
  • Blood and Blood Products
  • Cellular and Gene Therapy Products
  • Tissue and Tissue Products
  • Stem Cell Products
• Medical Devices
• Water Purification
• Air Purification

Virus Filtration End-use Outlook (Revenue, USD Million, 2018 - 2030)

• Biopharmaceutical Biotechnology Companies
• Contract Research Organizations
• Medical device companies
• Academic Institutes Research Laboratories

Virus Filtration Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
  • U.S.
  • Canada
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • Thailand
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Order a free sample PDF of the Virus Filtration Market Intelligence Study, published by Grand View Research.